You finish your morning coffee and wonder exactly when its effect will truly wear off. The answer comes down to two words: half-life. Understanding this pharmacokinetic concept explains why an espresso taken at 3pm can still disrupt your sleep — or not, depending on your profile. And it varies enormously from one person to the next.
What is a half-life?
In pharmacology, the elimination half-life is the time it takes for the body to eliminate half of the initial amount of a substance. For caffeine, this is not the moment you stop feeling its effect: it is an objective measure of plasma concentration.
In practical terms: if you drink a coffee containing 200 mg of caffeine, after one half-life you have around 100 mg remaining in your bloodstream. After two half-lives, around 50 mg. And so on, following an exponential decay known as first-order kinetics — the standard pharmacokinetic model for caffeine.
🔬 Key finding: In healthy adults, EFSA reports a mean caffeine half-life of approximately 4 hours, with a range of 2 to 8 hours. The pharmacokinetic literature reports values reaching up to 10 hours in some individuals. — EFSA (2015); Vidal.fr, caffeine drug interactions
The elimination curve, hour by hour
Caffeine is absorbed very rapidly. EFSA states that stimulant effects can begin 15 to 30 minutes after ingestion. Peak plasma concentration is generally reached within about one hour. After that, the liver takes over.
Caffeine remaining after a 200 mg coffee (theoretical half-life: 5 hours)
Scale: 0 to 300 mg. These values are theoretical and assume a half-life of 5 hours; actual half-life varies between individuals. Sources: EFSA (2015), Vidal.fr
These figures illustrate why residual caffeine at bedtime is so often underestimated. A 3pm coffee consumed by someone with a 7-hour half-life still leaves around 50 mg of active caffeine at 10:30pm — roughly the equivalent of half a long black. To visualise your own curve in real time, PauseCafé's active caffeine tracker calculates this residual hour by hour based on what you've drunk during the day.
The liver at the heart of elimination: the CYP1A2 enzyme
Caffeine is almost exclusively metabolised by the liver. One enzyme plays the lead role: cytochrome P450 1A2 (CYP1A2). According to a systematic review published in Frontiers in Pharmacology (Grzegorzewski et al., 2022), this enzyme is responsible for the vast majority of caffeine degradation, via a primary demethylation reaction that produces paraxanthine (approximately 80% of metabolites), theobromine and theophylline.
CYP1A2 activity varies considerably between individuals — by a factor of 5 to 6 according to data compiled in the same review — owing to genetic, environmental and hormonal factors. This variability is what explains the wide range of half-lives observed across the population.
🔬 Key finding: Genetic polymorphism of the CYP1A2 gene (notably the rs762551 variant) allows individuals to be classified as "fast", "intermediate" or "slow" metabolisers, with markedly different caffeine half-lives. — Sachse et al., British Journal of Clinical Pharmacology, 1999; cited in several recent reviews
For a deeper look at the genetic dimension, the article does your genetics determine your caffeine tolerance? explains how to identify your metaboliser profile.
Factors that alter your personal half-life
The average half-life is only a starting point. Several factors, well documented in the literature, can shorten or lengthen it significantly.
Smoking: shorter half-life
The polycyclic aromatic hydrocarbons in cigarette smoke strongly induce CYP1A2, accelerating caffeine breakdown. According to a systematic meta-analysis published in Frontiers in Pharmacology (Grzegorzewski et al., 2022), smoking consistently increases caffeine clearance and reduces its half-life across more than 50 years of pharmacokinetic research. Estimates commonly cited in the literature place the half-life in smokers at around 2 to 3.5 hours. Worth noting: when someone quits smoking, this effect gradually reverses — and the same caffeine dose can then last considerably longer.
Oral contraceptives: longer half-life
The synthetic oestrogens in the pill inhibit CYP1A2, slowing caffeine elimination. According to the same meta-analysis (Grzegorzewski et al., 2022), this effect is "consistent and reproducible" across decades of research. Published pharmacokinetic data suggest that women taking oral contraceptives may have a caffeine half-life of around 7 to 10 hours, compared with approximately 4 hours on average according to EFSA. In practice: a 2pm coffee may still be active at midnight.
Pregnancy: significantly extended half-life
Pregnancy profoundly alters hepatic metabolism. According to several primary literature sources, caffeine half-life during pregnancy is approximately 9 to 11 hours, and may extend further in the third trimester. This is one of the reasons official guidelines (ANSES, WHO) set a precautionary threshold of around 200 mg/day for pregnant women — well below the 400 mg/day recommended for adults generally. The article caffeine and pregnancy details these recommendations.
Age and liver health: variable effects
The enzymatic maturity of the liver varies with age. In newborns, and particularly in premature infants, caffeine half-life can reach 40 to 230 hours due to immature hepatic metabolism (clinical data cited in neonatal intensive care literature). In older adults, reduced hepatic blood flow can modestly extend the half-life. Additionally, any liver disease (cirrhosis, hepatitis) markedly reduces caffeine clearance, according to Grzegorzewski et al. (2022).
Genetics: fast or slow metaboliser?
Independently of environmental factors, your DNA directly influences how quickly you break down caffeine. The rs762551 polymorphism of the CYP1A2 gene broadly identifies three profiles:
- Fast metabolisers: half-life as low as 2–3 hours. These individuals can often drink a coffee in the late afternoon without it affecting their sleep.
- Intermediate metabolisers: half-life close to the population average.
- Slow metabolisers: half-life potentially exceeding 8 to 10 hours. For these people, a single cup in the mid-afternoon can still represent a significant concentration at bedtime.
Studies compiling data from thousands of subjects (Grzegorzewski et al., 2022, Frontiers in Pharmacology) show that CYP1A2 activity can vary by as much as 5 to 6 times between individuals, which explains radically different subjective experiences from the exact same cup of coffee.
🔬 Key finding: Caffeine half-life varies considerably among healthy adults depending on CYP1A2 genetic polymorphism, smoking habits, oral contraceptive use and liver health. — Vidal.fr
What this means for your daily routine
Knowing your own half-life enables informed decisions — not just about how many coffees you drink, but about their timing.
- Work backwards from your bedtime. If you go to bed at 11pm and your half-life is 5 hours, a coffee taken after 3pm will still leave around 100 mg active at sleep time. For someone with a 7-hour half-life, that critical cutoff moves back to 1pm.
- Account for your modifying factors. Have you recently quit smoking? Started or stopped the pill? Your half-life may have changed without you noticing.
- Don't think only in milligrams. The article caffeine and sleep quality is a reminder that it is not just the quantity, but the timing of consumption that determines the impact on your rest.
- Avoid accumulation. If your half-life is long, several coffees throughout the day can build up in your system. Caffeine tolerance can mask this effect, leading you to believe you "handle it well" while plasma concentration remains high.
Metabolites: an activity that lingers
One final point that is often overlooked: caffeine does not simply vanish. It transforms into partially active metabolites. Paraxanthine, the primary metabolite (approximately 80% of the degradation pathway), has stimulant properties of its own and a half-life comparable to that of caffeine. Theobromine and theophylline have distinct biological effects, notably cardiovascular and bronchodilatory. So even once caffeine itself has been reduced by 50%, the full range of active substances remains present in the body.
This is why the concept of "total active caffeine" — which combines the parent molecule and its active metabolites — is sometimes more clinically relevant than measuring plasma caffeine alone.
Limitations of this data and individual variability
The values cited in this article are averages or ranges drawn from group studies. They cannot accurately predict your personal half-life without a pharmacokinetic test (which remains in the clinical domain). Many other factors may play a role: general health, other medications (notably fluoroquinolone antibiotics or certain antidepressants that inhibit CYP1A2), dietary interactions, and hormonal fluctuations across the menstrual cycle. If you have any concerns about caffeine–medication interactions, consult a healthcare professional or your pharmacist.
Scientific sources
- Grzegorzewski J., Bartsch F., Köller A., König M. (2022). Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing. Frontiers in Pharmacology, 12:752826.
- Nehlig A. (2018). Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption. Pharmacological Reviews, 70(2):384–411.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (2015). Scientific Opinion on the safety of caffeine. EFSA Journal, 13(5):4102.
- Sachse C., Brockmöller J., Bauer S., Roots I. (1999). Functional Significance of a C→A Polymorphism in Intron 1 of the Cytochrome P450 CYP1A2 Gene Tested With Caffeine. British Journal of Clinical Pharmacology, 47(4):445–449.
- Vidal (2024). Caféine et médicaments : des interactions souvent méconnues. Vidal.fr — consulté octobre 2026.
⚕️ Important. This article is for information and general wellbeing only. It is not medical advice, a diagnosis or a prescription. The effects of caffeine vary from one person to another. If you have questions about your intake, or any symptom, pregnancy, medical treatment or health condition, speak to a healthcare professional (doctor, pharmacist). Do not change a treatment on the basis of this article alone.
PauseCafé